Chronic endotoxemia in subjects with type-1 diabetes is seen much before the onset of microvascular complications

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Aravindhan, Vivekanandhan ^a,b   Mohan, Viswanathan ^c   Arunkumar, Namasivayam ^d   Sandhya, Sreedharan ^a   Babu, Subash ^e  

^a ANNA UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

^c MADRAS DIABETES RESEARCH FOUNDATION   (India)

^d Biostatistics and Programming   (India)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN CORE ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MARKER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; CARRIER PROTEIN; CD14 ANTIGEN; CYTOKINE; LIPOPOLYSACCHARIDE-BINDING PROTEIN; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ENDOTOXEMIA; FEMALE; HUMAN; INDIAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ADOLESCENT; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; ANTIGENS, CD14; BIOMARKERS; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENDOTOXEMIA; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MALE; MEMBRANE GLYCOPROTEINS; MICROVESSELS; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947447601     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137618     Document Type: Article

References (32)

1. Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 2008; 7: 550-7. doi: 10.1016/j.autrev.2008.04.008 PMID: 18625444
2. Notkins AL. Immunologic and genetic factors in type 1 diabetes. J Biol Chem 2002; 277: 43545-8. PMID: 12270944
3. Peng H, Hagopian W. Environmental factors in the development of Type 1 diabetes. Rev Endocr Metab Disord 2006; 7: 149-62. PMID: 17203405
4. Cooper GS, Bynum ML, Somers EC. Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. J Autoimmun 2009; 33: 197-207. doi: 10.1016/j.jaut.2009.09.008 PMID: 19819109
5. Nistico L, Iafusco D, Galderisi A, Fagnani C, Cotichini R, Toccaceli V, et al. Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a Nationwide Italian Twin Study. J Clin Endocrinol Metab 2012; 97: E1483-91. PMID: 22569240
6. Vaarala O. Leaking gut in type 1 diabetes. Curr Opin Gastroenterol 2008; 24: 701-6. doi: 10.1097/MOG.0b013e32830e6d98 PMID: 19122519
7. Bosshart H, Heinzelmann M. Targeting bacterial endotoxin: two sides of a coin. Ann N Y Acad Sci 2007; 1096: 1-17. PMID: 17405910
8. Mussap M, Noto A, Fravega M, Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J Matern Fetal Neonatal Med 24 Suppl 2: 12-4.
9. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-42. doi: 10.1681/ASN.2007091048 PMID: 18256353
10. Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, et al. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45). Diabetes Care 2007; 30: 2019-24. PMID: 17488949
11. Mohan V, Shah S, Saboo B. Current glycemic status and diabetes related complications among type 2 diabetes patients in India: data from the A1chieve study. J Assoc Physicians India 2013; 61: 12-5.
12. Eshcol J, Jebarani S, Anjana RM, Mohan V, Pradeepa R. Prevalence, incidence and progression of peripheral arterial disease in Asian Indian type 2 diabetic patients. J Diabetes Complications 2014; 28: 627-31. doi: 10.1016/j.jdiacomp.2014.04.013 PMID: 24930714
13. Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-3. Diabetes Technol Ther 2015; 17: 112-8. doi: 10.1089/dia. 2014.0141 PMID: 25375662
14. Vaarala O, Atkinson MA, Neu J. The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity. Diabetes 2008; 57: 2555-62. doi: 10.2337/db08-0331 PMID: 18820210
15. Sapone A, de Magistris L, Pietzak M, Clemente MG, Tripathi A, Cucca F, et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006; 55: 1443-9. PMID: 16644703
16. Nymark M, Pussinen PJ, Tuomainen AM, Forsblom C, Groop PH, Lehto M. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care 2009; 32: 1689-93. doi: 10.2337/dc09-0467 PMID: 19502539
17. Lassenius MI, Pietilainen KH, Kaartinen K, Pussinen PJ, Syrjanen J, Forsblom C, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care 34: 1809-15. doi: 10.2337/dc10-2197 PMID: 21636801
18. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van't Veer C, Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. J Immunol 2003; 170: 1399-405. PMID: 12538700
19. Aravindhan V, Madhumitha H, Valarmathi S, Babu S. Increased Levels of Endotoxin Core Antibodies and Decreased Levels of sCD 14 Indicate Chronic Endotoxemia in Coronary Artery Disease (CURES-127). Journal of Clinical & Experimental Cardiology 2013; 4: 1-6.
20. Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013; 8: e54600. doi: 10.1371/journal.pone.0054600 PMID: 23349936
21. Monte SV, Caruana JA, Ghanim H, Sia CL, Korzeniewski K, Schentag JJ, et al. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus. Surgery 2012; 151: 587-93. doi: 10.1016/j. surg.2011.09.038 PMID: 22088821
22. Ruiz AG, Casafont F, Crespo J, Cayon A, Mayorga M, Estebanez A, et al. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 2007; 17: 1374-80. PMID: 18000721
23. Gutsmann T, Muller M, Carroll SF, MacKenzie RC, Wiese A, Seydel U. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001; 69: 6942-50. PMID: 11598069
24. Zweigner J, Gramm HJ, Singer OC, Wegscheider K, Schumann RR. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 2001; 98: 3800-8. PMID: 11739189
25. Lamping N, Dettmer R, Schroder NW, Pfeil D, Hallatschek W, Burger R, et al. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria. J Clin Invest 1998; 101: 2065-71. PMID: 9593762
26. Pavan Kumar N, Anuradha R, Andrade BB, Suresh N, Ganesh R, Shankar J, et al. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Vaccine Immunol 2013; 20: 704-11. doi: 10.1128/CVI.00038-13 PMID: 23486418
27. Anuradha R, George PJ, Pavan Kumar N, Fay MP, Kumaraswami V, Nutman TB, et al. Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease. PLoS Pathog 2012; 8: e1002749. doi: 10.1371/journal.ppat.1002749 PMID: 22685406
28. Moretti EW, Newman MF, Muhlbaier LH, Whellan D, Petersen RP, Rossignol D, et al. Effects of decreased preoperative endotoxin core antibody levels on long-term mortality after coronary artery bypass graft surgery. Arch Surg 2006; 141: 637-41; discussion 642. PMID: 16847232
29. Alkanani AK, Rewers M, Dong F, Waugh K, Gottlieb PA, Zipris D. Dysregulated Toll-like receptorinduced interleukin-1beta and interleukin-6 responses in subjects at risk for the development of type 1 diabetes. Diabetes 2012; 61: 2525-33. PMID: 22751696
30. Cavallo MG, Pozzilli P, Bird C, Wadhwa M, Meager A, Visalli N, et al. Cytokines in sera from insulindependent diabetic patients at diagnosis. Clin Exp Immunol 1991; 86: 256-9. PMID: 1934594
31. Surendar J, Mohan V, Pavankumar N, Babu S, Aravindhan V. Increased levels of serum granulocytemacrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99). Diabetes Technol Ther 2012; 14: 344-9. doi: 10.1089/dia.2011.0182 PMID: 22149626
32. Amutha A, Datta M, Unnikrishnan IR, Anjana RM, Rema M, Narayan KM, et al. Clinical profile of diabetes in the young seen between 1992 and 2009 at a specialist diabetes centre in south India. Prim Care Diabetes 2011; 5: 223-9. doi: 10.1016/j.pcd.2011.04.003 PMID: 21601548